We are a public investment issuer looking to create substantial value for our shareholders.

We look for and find great opportunities

Blackhawk Growth Corp. is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. We look for opportunities all over the globe where we can leverage our knowledge, expertise, and experience to deliver substantial growth for our companies and our investors.
View Our Portfolio

Our Portfolio

Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company’s strategy is focused on investing in multiple companies across a variety of sectors across North America.

Blackhawk Growth has the  rights to distribute a 2019-nCoV Ab test kit used in the detection of COVID-19 in Canada, the United States, Mexico, Germany, Switzerland and Austria.

An online clinic that connects doctors to their existing patients and allows new patients near instant access to a doctor from the comfort of their home.

Specializing in preservative-free shelf-stable baked goods. NuWave Foods is a fully licensed commercial kitchen and baked goods manufacturer located in Edmonton Alberta.

Launching edibles into ORBIT using high tech, space-age science
Recent

News Releases

View All

Blackhawk Signs MOU for Rights to Distribute Emergency Use Authorized PCR Test Kit and Additional Covid-19 Antibody Test

| News Release | No Comments
Vancouver, British Columbia - TheNewswire - August 4, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (OTC:BLRZF) (the "Corporation" or "Blackhawk"), is pleased to announce that it has entered into a Memorandum of Understanding (the "MOU"), dated effective August 3, 2020, with Medigen Biotechnology Corporation ("MBC") and its affiliate company, TBG Biotechnology Corp. ("TBG") to distribute an ExProbe SARS-CoV-2 Testing Kit…

Blackhawk Acquires California-Based Licensed Cannabis Producer

| News Release | No Comments
Vancouver, British Columbia - TheNewswire - July 28, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (Frankfurt:0JJ) US (OTC:BLRZF) (the "Company"), is pleased to announce that it has acquired all of the outstanding share capital of SAC Pharma Partners Inc. ("SAC Pharma"). SAC Pharma is a privately-owned British Columbia company which, through its wholly-owned subsidiary, SAC Pharma Partners USA, Inc. ("SAC…
Click To View

Management

Click To View

Stock Info